Is GPAT or GSHR more undervalued in 2026?

CirclFi compares GP-Act III Acquisition Corp. (GPAT) and Gesher Acquisition Corp. II (GSHR) using 13 institutional-grade valuation models. GPAT has a Quality of Company score of 4.5/10 while GSHR scores 4.7/10.

Which is a better buy — GPAT or GSHR?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do GPAT and GSHR valuations compare?

GPAT at $10.80 and GSHR at $10.40 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

GPAT vs GSHR Valuation Comparison 2026 — Intrinsic Value Analysis

GPAT

Blank Checks

GP-Act III Acquisition Corp.

Quality

4.5

out of 10

Value Trap

—

Price

$10.80

Last close

Models

11/13

Active

GSHR

Blank Checks

Gesher Acquisition Corp. II

Quality

4.7

out of 10

Value Trap

—

Price

$10.40

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	GPAT Fair Value	GPAT Upside	GSHR Fair Value	GSHR Upside
Bayesian DCF	Intrinsic	$1.28	-88.1%	$0.88	-91.6%
Earnings Power Value	Intrinsic	$1.67	-84.6%	$0.90	-91.4%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for GPAT vs GSHR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

GPAT vs GSHR — Which Stock Is More Undervalued?

GSHR scores higher with a 4.7/10 quality rating vs GPAT's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing GP-Act III Acquisition Corp. (GPAT) and Gesher Acquisition Corp. II (GSHR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

GPAT currently trades at $10.80 with a QOC of 4.5/10, while GSHR trades at $10.40 with a QOC of 4.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).